Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. (TRDA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
trda · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$21.00
Consensus
$16.00
+155.6% upside
Low
$10.00
Median: $17 · Last Close: $6.26
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$16.00
155.6% upside
High Target
$21
235.5%
Low Target
$10
59.7%
Current Price
$6.26
as of today
Based on analyst price targets, the TRDA stock price prediction for the next 12 months ranges from $10 to $21. The consensus TRDA price forecast of $16.00 implies 155.6% upside from the current price of $6.26.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.23 | ↓ 0.42% |
1-day model range: $6.1–$6.37. Peak: $6.37 (-0.42%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | +27.0% |
| 2028 | $9 | +44.1% |
| 2029 | $10 | +53.8% |
| 2030 | $10 | +59.0% |
| 2031 | — | +61.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TRDA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-04-06 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-06 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-08-26 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Entrada Therapeutics, Inc. (TRDA) stock. Of the recent 25 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover TRDA.
Analyst Recommendation Trends
TRDA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$20M
↓ 64.7% YoY
Revenue Next Year
$29M
↑ 49.6% YoY
EPS This Year
$-3.96
EPS Next Year
$-3.58
↓ 9.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast TRDA EPS of $-3.96 for the current fiscal year, based on estimates from 6 analysts. The TRDA revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TRDA stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TRDA price target is $16.00 (+155.6% upside), with an analyst consensus of Buy.
The TRDA short-term stock prediction for tomorrow is $6.23 (-0.42%). The TRDA stock price prediction for 2027 estimates an average of $8. The TRDA stock prediction for 2030 projects a range of $8–$12.
Entrada Therapeutics, Inc. trades on NASDAQ under the ticker TRDA. The TRDA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
TRDA forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month TRDA price target is $16.00, with a high forecast of $21.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +155.6% potential upside from the current price of $6.26.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.